I would like to express my gratitude to the European Academy of Neurology for awarding me with research-experience fellowship at Prof. Bastiaan Bloem’s research group at the Department of Neurology, Radboud University, Nijmegen, The Netherlands.

This year, the hospital visit of the Resident and Research Fellow Section (RRFS) of the European Academy of Neurology during the EAN congress was on Monday 18th June 2018. Sixty-seven residents and research fellows from 16 different countries mainly around Europe but also including countries from Africa went to the Hospital de Santa Maria which is one of the university hospitals of Lisbon.

Biomed Alliance: Prof. Axel Pries, President of the Biomed Alliance, meets with MEP Christian Ehler, rapporteur to the EP for the EC Horizon Europe Framework.   In view of the ongoing political discussions around the European Commission’s proposal for funding… Continue Reading

                                                 Thanks to a memorandum of understanding between the European academy of neurology (EAN) and the African academy of neurology (AFAN), for the second year, AFAN has had an exhibition stand at the EAN congress; this year in Lisbon, Portugal.… Continue Reading

Last week marked the launch of the EBC statement “Counting down to zero: Towards a future with underfunded health research?”, which calls on the European Commission, the European Parliament and the Council of the European Union to increase the budget of the 9th Framework Programme of Research & Innovation, or “Horizon Europe”, to at least €120 billion.

Please find below articles from German authors and co-authors that were published in the European Journal of Neurology

The 2018 recipients, Prof. Amadou Gallo Diop (Senegal) and Prof. Riadh Gouider (Tunisia) have contributed exceptionally to develop neurology in Africa and to strengthen the relations between African neurology and EAN. The EAN Service Award comes with an official document and a personalized golden hammer.

The mission of EAN is ‘to promote excellence in neurology across Europe’. Therefore we need you, our colleagues, to become individual EAN members. Membership is not only for your own benefit, but also to accomplish our mission. As an individual member you can play an important role. By standing for election for the position as Delegate in the Assembly of Delegates you can become an influencer.

For August 2018, we have selected: Corvol JC, Artaud F, Cornier-Dequaire F, et al., for the DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 2018. doi:10.1212/WNL.0000000000005816. Impulse control disorders (ICDs) are frequent in Parkinson’s disease (PD) patients, and can have relevant consequences on social life. Whereas the association between treatment with dopamine agonists (DA) and the onset of ICDs is well known, there is controversy about the relationship with dose and duration of DA therapy.

The roots of clinical neurology can be traced back to Germany. With his ”Lehrbuch der Nervenkrankheiten des Menschen“ (textbook of human nervous diseases) 1840, Moritz Heinrich Romberg (1795 – 1873) established the foundation of clinical neurology as we know it today. His work was the first and for decades the only systematic representation of neurological diseases in Europe and America, bringing him international fame and esteem.

Prof. David B. Vodušek (DBV): Kindly illustrate the history, vision and mission of the EANM – European Association of  Nuclear Medicine to the readers of the EAN Pages. Prof. K. Muylle (KM): The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association, incorporated in Vienna/Austria. The EANM’s vision is to optimise and advance science and education in nuclear medicine for the benefit of public health and humanity within the concept of personalised healthcare. The EANM acts as umbrella organisation for individuals as well as national societies.

The latest CME article July 2018: “Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale” is online! Please log-in and browse to the LEARN  section on the EAN Website and answer the questions! All e-learning activities… Continue Reading

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

Please find below articles from Polish authors and co-authors that were published in the European Journal of Neurology

The Guideline will address important areas of dementia management where the medical doctor plays a pivotal role, which includes treatment of epilepsy in dementia, pain in dementia, treatment with antipsychotics in dementia, vascular risk factors in dementia and systematic medical follow-up in dementia.